Edward Franz Pace-Schott, Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Extinction, Psychological | 19 | 2024 | 367 | 5.090 |
Why?
|
| Fear | 22 | 2024 | 1496 | 3.720 |
Why?
|
| Sleep | 34 | 2023 | 4816 | 2.450 |
Why?
|
| Conditioning, Classical | 12 | 2024 | 368 | 2.050 |
Why?
|
| Mental Recall | 11 | 2023 | 1218 | 1.590 |
Why?
|
| Sleep Initiation and Maintenance Disorders | 9 | 2022 | 1107 | 1.510 |
Why?
|
| Memory | 10 | 2020 | 2192 | 1.430 |
Why?
|
| Dreams | 12 | 2021 | 145 | 1.270 |
Why?
|
| Stress Disorders, Post-Traumatic | 9 | 2023 | 4629 | 1.270 |
Why?
|
| Arousal | 8 | 2023 | 1174 | 1.170 |
Why?
|
| Sleep, REM | 17 | 2022 | 593 | 1.140 |
Why?
|
| Galvanic Skin Response | 12 | 2024 | 359 | 1.060 |
Why?
|
| Emotions | 9 | 2023 | 2760 | 0.980 |
Why?
|
| Implosive Therapy | 3 | 2018 | 127 | 0.940 |
Why?
|
| Wakefulness | 14 | 2018 | 1282 | 0.930 |
Why?
|
| Amygdala | 8 | 2024 | 1375 | 0.790 |
Why?
|
| Cocaine-Related Disorders | 6 | 2010 | 458 | 0.790 |
Why?
|
| Habituation, Psychophysiologic | 2 | 2014 | 144 | 0.760 |
Why?
|
| Polysomnography | 16 | 2022 | 1868 | 0.740 |
Why?
|
| Substance Withdrawal Syndrome | 6 | 2010 | 627 | 0.670 |
Why?
|
| Circadian Rhythm | 10 | 2014 | 2591 | 0.630 |
Why?
|
| Sleep Deprivation | 3 | 2020 | 848 | 0.610 |
Why?
|
| Anxiety Disorders | 4 | 2022 | 2745 | 0.610 |
Why?
|
| Autonomic Nervous System | 2 | 2021 | 707 | 0.580 |
Why?
|
| Nerve Net | 5 | 2024 | 2307 | 0.530 |
Why?
|
| Neuropsychology | 1 | 2016 | 110 | 0.510 |
Why?
|
| Hypothalamo-Hypophyseal System | 1 | 2019 | 703 | 0.480 |
Why?
|
| Psychotherapy, Group | 1 | 2018 | 417 | 0.470 |
Why?
|
| Refugees | 1 | 2022 | 615 | 0.460 |
Why?
|
| Evoked Potentials | 1 | 2019 | 1050 | 0.420 |
Why?
|
| Spiders | 1 | 2012 | 11 | 0.410 |
Why?
|
| Stress, Psychological | 3 | 2019 | 4526 | 0.390 |
Why?
|
| Rest | 1 | 2017 | 941 | 0.390 |
Why?
|
| Learning | 6 | 2023 | 1754 | 0.380 |
Why?
|
| Neural Pathways | 3 | 2024 | 3078 | 0.380 |
Why?
|
| Cognition | 9 | 2011 | 7059 | 0.370 |
Why?
|
| Electromyography | 5 | 2021 | 1398 | 0.360 |
Why?
|
| Symbolism | 1 | 2010 | 32 | 0.340 |
Why?
|
| Phobic Disorders | 1 | 2012 | 440 | 0.330 |
Why?
|
| Generalization, Stimulus | 1 | 2009 | 13 | 0.320 |
Why?
|
| Gyrus Cinguli | 5 | 2018 | 1118 | 0.320 |
Why?
|
| Brain | 9 | 2024 | 27163 | 0.280 |
Why?
|
| Heart Rate | 5 | 2021 | 4209 | 0.280 |
Why?
|
| Young Adult | 24 | 2024 | 59980 | 0.260 |
Why?
|
| Saliva | 3 | 2018 | 853 | 0.260 |
Why?
|
| Photic Stimulation | 4 | 2021 | 1989 | 0.260 |
Why?
|
| Hypnotics and Sedatives | 2 | 2011 | 1193 | 0.250 |
Why?
|
| Aging | 3 | 2015 | 8729 | 0.250 |
Why?
|
| Humans | 72 | 2024 | 767040 | 0.240 |
Why?
|
| Actigraphy | 2 | 2019 | 527 | 0.240 |
Why?
|
| Fluvoxamine | 2 | 2001 | 77 | 0.230 |
Why?
|
| Paroxetine | 2 | 2001 | 181 | 0.220 |
Why?
|
| Adult | 38 | 2024 | 223317 | 0.220 |
Why?
|
| Consciousness | 4 | 2002 | 602 | 0.210 |
Why?
|
| Affect | 1 | 2011 | 1494 | 0.210 |
Why?
|
| Cerebral Cortex | 1 | 2019 | 5754 | 0.210 |
Why?
|
| Neuropsychological Tests | 6 | 2011 | 7121 | 0.210 |
Why?
|
| Hydrocortisone | 3 | 2018 | 1840 | 0.210 |
Why?
|
| Magnetic Resonance Imaging | 12 | 2024 | 36582 | 0.200 |
Why?
|
| Cognition Disorders | 2 | 2008 | 3968 | 0.200 |
Why?
|
| Parasympathetic Nervous System | 1 | 2022 | 144 | 0.190 |
Why?
|
| Personal Space | 1 | 2021 | 36 | 0.190 |
Why?
|
| Psychomotor Performance | 2 | 2012 | 1886 | 0.190 |
Why?
|
| Self Report | 4 | 2019 | 3773 | 0.180 |
Why?
|
| Prosencephalon | 1 | 2002 | 305 | 0.180 |
Why?
|
| Adolescent | 16 | 2024 | 89046 | 0.170 |
Why?
|
| Male | 40 | 2024 | 364203 | 0.170 |
Why?
|
| Prefrontal Cortex | 4 | 2024 | 2224 | 0.160 |
Why?
|
| Female | 39 | 2024 | 396660 | 0.150 |
Why?
|
| Space Perception | 1 | 2021 | 468 | 0.150 |
Why?
|
| Sleep Stages | 6 | 2011 | 705 | 0.140 |
Why?
|
| Grief | 1 | 2020 | 256 | 0.140 |
Why?
|
| Analysis of Variance | 4 | 2014 | 6215 | 0.140 |
Why?
|
| Decision Making | 1 | 2011 | 3951 | 0.140 |
Why?
|
| Hippocampus | 3 | 2018 | 3777 | 0.130 |
Why?
|
| Communicable Disease Control | 1 | 2022 | 856 | 0.130 |
Why?
|
| Bereavement | 1 | 2020 | 309 | 0.120 |
Why?
|
| Reaction Time | 4 | 2012 | 2086 | 0.120 |
Why?
|
| Basal Metabolism | 1 | 2016 | 163 | 0.120 |
Why?
|
| Contraceptives, Oral, Hormonal | 1 | 2015 | 190 | 0.110 |
Why?
|
| Autonomic Nervous System Diseases | 1 | 2017 | 270 | 0.110 |
Why?
|
| Statistics as Topic | 3 | 2016 | 2350 | 0.100 |
Why?
|
| Crime Victims | 1 | 2017 | 348 | 0.100 |
Why?
|
| Psychophysics | 1 | 2013 | 292 | 0.100 |
Why?
|
| Smoking | 3 | 2008 | 9081 | 0.100 |
Why?
|
| Self Administration | 3 | 2008 | 386 | 0.100 |
Why?
|
| Dyssomnias | 1 | 2011 | 28 | 0.100 |
Why?
|
| Brain Mapping | 5 | 2024 | 6597 | 0.100 |
Why?
|
| Parasomnias | 1 | 2011 | 27 | 0.090 |
Why?
|
| Central Nervous System Stimulants | 2 | 2010 | 1168 | 0.090 |
Why?
|
| Violence | 1 | 2017 | 931 | 0.090 |
Why?
|
| REM Sleep Behavior Disorder | 1 | 2011 | 111 | 0.080 |
Why?
|
| Cocaine | 3 | 2010 | 944 | 0.080 |
Why?
|
| Verbal Learning | 1 | 2012 | 459 | 0.080 |
Why?
|
| Middle Aged | 14 | 2022 | 223233 | 0.080 |
Why?
|
| Anxiety | 4 | 2024 | 4670 | 0.080 |
Why?
|
| Electroshock | 1 | 2009 | 120 | 0.080 |
Why?
|
| Cross-Sectional Studies | 3 | 2022 | 26325 | 0.080 |
Why?
|
| Motor Skills | 1 | 2012 | 521 | 0.080 |
Why?
|
| Brain Chemistry | 1 | 2012 | 951 | 0.080 |
Why?
|
| Models, Animal | 1 | 2015 | 2121 | 0.080 |
Why?
|
| Estradiol | 1 | 2015 | 1951 | 0.080 |
Why?
|
| Oxytocin | 1 | 2012 | 403 | 0.080 |
Why?
|
| Mental Health | 1 | 2022 | 3272 | 0.070 |
Why?
|
| Crack Cocaine | 1 | 2008 | 33 | 0.070 |
Why?
|
| Object Attachment | 1 | 2011 | 326 | 0.070 |
Why?
|
| Attention | 2 | 2009 | 2413 | 0.070 |
Why?
|
| Body Temperature | 1 | 2011 | 780 | 0.070 |
Why?
|
| Connecticut | 1 | 2008 | 365 | 0.070 |
Why?
|
| Association Learning | 1 | 2009 | 219 | 0.070 |
Why?
|
| Oxygen | 1 | 2018 | 4252 | 0.070 |
Why?
|
| Task Performance and Analysis | 1 | 2010 | 771 | 0.070 |
Why?
|
| gamma-Aminobutyric Acid | 1 | 2012 | 1139 | 0.060 |
Why?
|
| New York | 1 | 2008 | 879 | 0.060 |
Why?
|
| Sex Characteristics | 1 | 2015 | 2647 | 0.060 |
Why?
|
| Time Factors | 5 | 2014 | 40154 | 0.060 |
Why?
|
| Neuronal Plasticity | 2 | 2022 | 1446 | 0.050 |
Why?
|
| Benzhydryl Compounds | 1 | 2010 | 944 | 0.050 |
Why?
|
| Testosterone | 1 | 2013 | 2490 | 0.050 |
Why?
|
| Executive Function | 1 | 2011 | 1396 | 0.050 |
Why?
|
| Animals | 7 | 2015 | 168965 | 0.050 |
Why?
|
| Pandemics | 1 | 2022 | 8736 | 0.050 |
Why?
|
| Clinical Protocols | 1 | 2008 | 1443 | 0.050 |
Why?
|
| Attention Deficit Disorder with Hyperactivity | 1 | 2017 | 3724 | 0.050 |
Why?
|
| Severity of Illness Index | 1 | 2019 | 15925 | 0.050 |
Why?
|
| Skin Physiological Phenomena | 1 | 2021 | 193 | 0.040 |
Why?
|
| Reference Values | 1 | 2008 | 4918 | 0.040 |
Why?
|
| Sex Offenses | 1 | 2024 | 355 | 0.040 |
Why?
|
| Biological Clocks | 1 | 2002 | 320 | 0.040 |
Why?
|
| Visual Perception | 1 | 2008 | 1392 | 0.040 |
Why?
|
| Diagnosis, Computer-Assisted | 1 | 2005 | 700 | 0.040 |
Why?
|
| Periodicity | 1 | 2001 | 347 | 0.040 |
Why?
|
| Chronic Disease | 2 | 2005 | 9362 | 0.040 |
Why?
|
| Homeostasis | 1 | 2011 | 3345 | 0.040 |
Why?
|
| Cues | 1 | 2024 | 877 | 0.040 |
Why?
|
| Electrocardiography | 1 | 2012 | 6409 | 0.040 |
Why?
|
| Students | 1 | 2009 | 1744 | 0.040 |
Why?
|
| Gravitation | 1 | 1998 | 82 | 0.040 |
Why?
|
| Biological Specimen Banks | 1 | 2022 | 787 | 0.030 |
Why?
|
| Citalopram | 1 | 2020 | 402 | 0.030 |
Why?
|
| Double-Blind Method | 3 | 2024 | 12451 | 0.030 |
Why?
|
| Random Allocation | 1 | 2001 | 2394 | 0.030 |
Why?
|
| Rape | 1 | 2017 | 131 | 0.030 |
Why?
|
| Treatment Outcome | 3 | 2020 | 65295 | 0.030 |
Why?
|
| Synaptic Transmission | 1 | 2002 | 1175 | 0.030 |
Why?
|
| Vestibule, Labyrinth | 1 | 1998 | 235 | 0.030 |
Why?
|
| Aged | 4 | 2018 | 171319 | 0.030 |
Why?
|
| Muscle, Skeletal | 1 | 2010 | 4968 | 0.030 |
Why?
|
| Tomography, Emission-Computed | 1 | 1998 | 1007 | 0.030 |
Why?
|
| Models, Neurological | 1 | 2002 | 1747 | 0.030 |
Why?
|
| Avoidance Learning | 1 | 2015 | 248 | 0.030 |
Why?
|
| Monitoring, Physiologic | 1 | 2001 | 1794 | 0.030 |
Why?
|
| Longitudinal Studies | 2 | 2008 | 14766 | 0.030 |
Why?
|
| Pyridines | 1 | 2004 | 2890 | 0.030 |
Why?
|
| Energy Metabolism | 1 | 2002 | 2906 | 0.020 |
Why?
|
| Adaptation, Physiological | 1 | 1998 | 1312 | 0.020 |
Why?
|
| C-Reactive Protein | 1 | 2022 | 3851 | 0.020 |
Why?
|
| Psychological Theory | 1 | 2011 | 172 | 0.020 |
Why?
|
| Intelligence Tests | 1 | 2011 | 504 | 0.020 |
Why?
|
| Substance Abuse Treatment Centers | 1 | 2010 | 155 | 0.020 |
Why?
|
| Electroencephalography | 3 | 2000 | 6282 | 0.020 |
Why?
|
| Drug Administration Schedule | 2 | 2010 | 4855 | 0.020 |
Why?
|
| Neurons | 2 | 1998 | 9517 | 0.020 |
Why?
|
| Gambling | 1 | 2010 | 192 | 0.020 |
Why?
|
| Reading | 1 | 2011 | 541 | 0.020 |
Why?
|
| Models, Psychological | 1 | 2011 | 823 | 0.020 |
Why?
|
| Narcotics | 1 | 2008 | 332 | 0.020 |
Why?
|
| Awareness | 1 | 2010 | 653 | 0.020 |
Why?
|
| Health Status Indicators | 1 | 2011 | 969 | 0.020 |
Why?
|
| Medical Records | 1 | 2011 | 1409 | 0.020 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2012 | 3804 | 0.020 |
Why?
|
| Comorbidity | 1 | 2020 | 10582 | 0.020 |
Why?
|
| Retrospective Studies | 1 | 2013 | 81659 | 0.010 |
Why?
|
| Diagnostic Imaging | 1 | 1998 | 3530 | 0.010 |
Why?
|
| Magnetic Resonance Spectroscopy | 1 | 2012 | 3684 | 0.010 |
Why?
|
| Placebo Effect | 1 | 2005 | 516 | 0.010 |
Why?
|
| Blood Glucose | 1 | 2016 | 6421 | 0.010 |
Why?
|
| Placebos | 1 | 2005 | 1660 | 0.010 |
Why?
|
| Psychometrics | 1 | 2011 | 3060 | 0.010 |
Why?
|
| Psychophysiology | 1 | 2000 | 136 | 0.010 |
Why?
|
| Depression | 1 | 2020 | 8234 | 0.010 |
Why?
|
| Positron-Emission Tomography | 1 | 2016 | 6550 | 0.010 |
Why?
|
| Eyelids | 1 | 2001 | 278 | 0.010 |
Why?
|
| Quality of Life | 1 | 2020 | 13485 | 0.010 |
Why?
|
| Monitoring, Ambulatory | 1 | 2001 | 357 | 0.010 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2010 | 10748 | 0.010 |
Why?
|
| Mental Processes | 1 | 1998 | 242 | 0.010 |
Why?
|
| Head | 1 | 2001 | 926 | 0.010 |
Why?
|
| Movement | 1 | 2001 | 1473 | 0.010 |
Why?
|
| Case-Control Studies | 1 | 2012 | 22254 | 0.010 |
Why?
|
| Life Style | 1 | 2005 | 3931 | 0.010 |
Why?
|
| Clinical Trials as Topic | 1 | 2009 | 8048 | 0.010 |
Why?
|
| Equipment Design | 1 | 2001 | 3489 | 0.010 |
Why?
|
| Cohort Studies | 1 | 2016 | 41718 | 0.010 |
Why?
|
| Alcohol Drinking | 1 | 2005 | 4045 | 0.010 |
Why?
|
| Combined Modality Therapy | 1 | 2004 | 8535 | 0.010 |
Why?
|
| Boston | 1 | 2002 | 9360 | 0.000 |
Why?
|
| Risk Factors | 1 | 2011 | 74886 | 0.000 |
Why?
|
| Follow-Up Studies | 1 | 2004 | 39317 | 0.000 |
Why?
|
| Models, Biological | 1 | 1998 | 9464 | 0.000 |
Why?
|
| Prospective Studies | 1 | 2004 | 54886 | 0.000 |
Why?
|